Connection

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Search Results to Carolina Schinke

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Schinke, Carolina

One or more keywords matched the following properties of Schinke, Carolina

Property

Value

overview

Dr. Carolina Schinke is an Associate Professor of Medicine at the Myeloma Institute for Research and Therapy at UAMS and joined the department in 2014. She completed her fellowship in Hematology/Oncology in 2013 at Montefiore Medical Center in New York and performed a research fellowship in molecular and translational science at Einstein, New York in 2014 . She earned her medical degree at the University of Halle in Germany and completed her residency at the Jacobi Medical Center in New York in 2010. Dr. Schinke has several publications and scientific poster presentations/abstracts and is a member of the American Society of Hematology, American Society of Oncology and International Myeloma Society. Her clinical interests are plasma cell dyscrasias, including MGUS, smoldering multiple myeloma, plasma cell leukemia as well as amyloid disease and Waldenstroms.

One or more keywords matched the following items that are connected to Schinke, Carolina

Item Type	Name
Academic Article	Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis.
Concept	Multiple Myeloma
Academic Article	Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?
Academic Article	Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.
Academic Article	CA-125 secreting IgG kappa multiple myeloma.
Academic Article	Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma.
Academic Article	Gastrointestinal histoplasmosis in a patient after autologous stem cell transplant for multiple myeloma.
Academic Article	Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple Myeloma.
Academic Article	The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype.
Academic Article	The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma.
Academic Article	Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.
Academic Article	Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma.
Academic Article	Enterococcus raffinosus infection with atypical hemolytic uremic syndrome in a multiple myeloma patient after autologous stem cell transplant.
Academic Article	Cardiovascular complications of multiple myeloma in the elderly.
Academic Article	The Pattern of Mesenchymal Stem Cell Expression Is an Independent Marker of Outcome in Multiple Myeloma.
Academic Article	Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma.
Academic Article	The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma.
Academic Article	Kinase domain activation through gene rearrangement in multiple myeloma.
Academic Article	FRAX is a robust predictor of baseline vertebral fractures in multiple myeloma patients.
Academic Article	Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes.
Academic Article	Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomes.
Academic Article	Poor overall survival in hyperhaploid multiple myeloma is defined by double-hit bi-allelic inactivation of TP53.
Academic Article	Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?
Academic Article	An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome.
Academic Article	Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias.
Academic Article	Daratumumab in high-risk relapsed/refractory multiple myeloma patients: adverse effect of chromosome 1q21 gain/amplification and GEP70 status on outcome.
Academic Article	Long-term outcomes after autologous stem cell transplantation for multiple myeloma.
Academic Article	BRAF and DIS3 Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple Myeloma.
Academic Article	Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease.
Academic Article	The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma.
Academic Article	Monitoring treatment response and disease progression in myeloma with circulating cell-free DNA.
Academic Article	Clinical characteristics of testicular extramedullary involvement in multiple myeloma.
Academic Article	The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma.
Academic Article	Bone remineralization of lytic lesions in multiple myeloma - The Arkansas experience.
Academic Article	PHF19 inhibition as a therapeutic target in multiple myeloma.
Academic Article	Persistent bone marrow minimal residual disease as a "high-risk" disease feature in multiple myeloma.
Academic Article	High-risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse.
Academic Article	Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups.
Academic Article	Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.
Academic Article	Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma.
Academic Article	The Role of Monoclonal Antibodies in the Era of Bi-Specifics Antibodies and CAR T Cell Therapy in Multiple Myeloma.
Academic Article	Hematological and infectious complications with CD38 antigen targeting monoclonal antibody-based therapies in multiple myeloma: A meta-analysis of randomized control trials.
Academic Article	Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma.
Academic Article	Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.
Academic Article	Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma.
Academic Article	Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission.
Academic Article	Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant Neoplasms.
Academic Article	Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.
Academic Article	CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation.
Academic Article	Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level.
Academic Article	The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states.
Academic Article	Editorial: The role of the bone marrow microenvironment in multiple myeloma evolution and therapy.
Academic Article	Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma.
Academic Article	Variability of definition of high-risk multiple myeloma across phase III clinical trials.
Academic Article	Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis.
Academic Article	Racial Differences in Spinal Cord Compression Related Hospitalizations in Patients with Multiple Myeloma.
Academic Article	Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy.
Academic Article	Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience.
Academic Article	Gender disparities in multiple myeloma publications.
Academic Article	Geographic and Racial Disparities in Access to Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials for Multiple Myeloma.
Academic Article	A gene signature can predict risk of MGUS progressing to multiple myeloma.
Academic Article	A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy.
Academic Article	Growth and dormancy control of myeloma cells by mesenchymal stem cells.
Academic Article	The Immune Microenvironment in Multiple Myeloma Progression at a Single-cell Level.
Academic Article	Under-representation of black patients with multiple myeloma in studies supporting International Myeloma Working Group guidelines.
Academic Article	The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.
Academic Article	Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States.
Academic Article	BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions.
Academic Article	High NEK2 expression in myeloid progenitors suppresses T?cell immunity in multiple myeloma.
Academic Article	Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma: TAURUS Chart Review Study.
Grant	MAGNETISMM-4 A Phase 1b/2, Open Label Umbrella Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA) CD3 Bispecific Antibody, in Combination with Other Anti-Cancer Treatments in Participants with Multiple Myeloma
Grant	MAGNETISMM-4 A Phase 1b/2, Open Label Umbrella Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA) CD3 Bispecific Antibody, in Combination with Other Anti-Cancer Treatments in Participants with Multiple Myeloma
Academic Article	Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up.
Academic Article	Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.
Academic Article	Impact of Clonal Heterogeneity in Multiple Myeloma.
Academic Article	Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
Academic Article	Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma.
Academic Article	A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma.
Academic Article	Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study.
Academic Article	Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
Academic Article	The impressive efficacy of anti-G protein-coupled receptor, class C group 5 member D chimeric antigen receptor T cells in patients with relapsed or refractory multiple myeloma.
Academic Article	CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients.

Search Criteria

Multiple Myeloma